Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuvalent Inc Cl A (NUVL)

Nuvalent Inc Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvalent Inc Cl A One Broadway 14thFloor Cambridge MA 02142 USA

www.nuvalent.com Employees: 92 P: 857-357-7000

Description:

Nuvalent Inc. is a biopharmaceutical company. It focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. The company's program pipeline includes ROS1-positive and ALK-positive NSCLC. Nuvalent Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 5,984,084
Enterprise Value, $K 5,648,694
Shares Outstanding, K 71,053
Annual Sales, $ 0 K
Annual Net Income, $ -126,220 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -84,350 K
EBIT, $ -240,510 K
EBITDA, $ -250,620 K
60-Month Beta 1.31
% of Insider Shareholders 12.52%
% of Institutional Shareholders 97.26%
Float, K 62,157
% Float 87.48%
Short Volume Ratio 0.78

Growth:

1-Year Return 16.87%
3-Year Return 338.19%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.28 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -3.47
EPS Growth vs. Prev Qtr -45.45%
EPS Growth vs. Prev Year -116.95%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NUVL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.63%
Return-on-Assets % -27.15%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.35
Book Value/Share 15.81
Interest Coverage -2.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar